March hemoglobinuria.
PLUMB RT.
J Urol. 1951 Apr;65(4):655-9. doi: 10.1016/S0022-5347(17)68533-1.
Monoclonal Antibodies: A Review.
Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, Chugh VK.
Curr Clin Pharmacol. 2018;13(2):85-99. doi: 10.2174/1574884712666170809124728.
March hemoglobinuria-associated acute tubular injury.
Khalighi MA, Henriksen KJ, Chang A, Meehan SM.
Clin Kidney J. 2014 Oct;7(5):488-9. doi: 10.1093/ckj/sfu078. Epub 2014 Sep 4.
March hemoglobinuria progressed to acute kidney injury after kendo practice: a case report.
Yoshida M, Suzuki H, Hamaguchi S, Iwasaki M, Fukuda H, Takahara H, Tomita S, Suzuki Y.
BMC Nephrol. 2022 Nov 16;23(1):368. doi: 10.1186/s12882-022-02988-0.
[March hemoglobinuria].
Trincão C.
An Inst Med Trop (Lisb). 1966 Jul-Dec;23(3-4):523-8.
March hemoglobinuria.
KURZ ER.
Brooklyn Hosp J. 1948 Apr;6(2):91-4.
March hemoglobinuria.
PLUMB RT.
Trans West Sect Am Urol Assoc. 1950;17:146-51.
March haemoglobinuria.
BELL AM.
Can Med Assoc J. 1947 Jul;57(1):43-6.
Crovalimab: First Approval.
Dhillon S.
Drugs. 2024 Jun;84(6):707-716. doi: 10.1007/s40265-024-02032-5. Epub 2024 May 14.
March Haemoglobinuria.
Palmer RA, Mitchell HS.
Can Med Assoc J. 1943 Dec;49(6):465-72.
